MeCP2, a key contributor to neurological disease, activates and represses transcription
about
Anaplerotic triheptanoin diet enhances mitochondrial substrate use to remodel the metabolome and improve lifespan, motor function, and sociability in MeCP2-null miceSex-dependent association of common variants of microcephaly genes with brain structureKaiso is a bimodal modulator for Wnt/beta-catenin signalingMethyl-CpG-binding protein 2 is phosphorylated by homeodomain-interacting protein kinase 2 and contributes to apoptosisDNA methylation and memory formationLasting epigenetic influence of early-life adversity on the BDNF geneAutism risk factors: genes, environment, and gene-environment interactionsTrisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteinsThe epigenetic landscape of addictionBeyond the monoaminergic hypothesis: neuroplasticity and epigenetic changes in a transgenic mouse model of depressionPathogenesis of lethal cardiac arrhythmias in Mecp2 mutant mice: implication for therapy in Rett syndromeHistone methylation regulates memory formation.CNV and nervous system diseases--what's new?Neonatal MeCP2 is important for the organization of sex differences in vasopressin expressionMedicine. Activating a repressorBalanced gene regulation by an embryonic brain ncRNA is critical for adult hippocampal GABA circuitryTranscription factor MEF2C influences neural stem/progenitor cell differentiation and maturation in vivoThe common BDNF polymorphism may be a modifier of disease severity in Rett syndromeCDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tailPartial reversal of Rett Syndrome-like symptoms in MeCP2 mutant miceLoss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalitiesEpigenetic mechanisms in schizophreniaReciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autismEpigenetic principles and mechanisms underlying nervous system functions in health and diseaseWhere Environment Meets Cognition: A Focus on Two Developmental Intellectual Disability DisordersThe Interaction between the Immune System and Epigenetics in the Etiology of Autism Spectrum DisordersModifiers and Readers of DNA Modifications and Their Impact on Genome Structure, Expression, and Stability in DiseasePotential Role of Epigenetic Mechanism in Manganese Induced NeurotoxicityEmerging Molecular and Biological Functions of MBD2, a Reader of DNA MethylationMeCP2 and the enigmatic organization of brain chromatin. Implications for depression and cocaine addictionClinical and Neurobiological Relevance of Current Animal Models of Autism Spectrum Disorders.Emerging Roles of BAI Adhesion-GPCRs in Synapse Development and PlasticityDevelopmental Dynamics of Rett SyndromeTargeting New Candidate Genes by Small Molecules Approaching Neurodegenerative DiseasesEpigenetic Research of Neurodegenerative Disorders Using Patient iPSC-Based ModelsRett Syndrome: Crossing the Threshold to Clinical TranslationGenes, circuits, and precision therapies for autism and related neurodevelopmental disordersNew Insights on Astrocyte Ion Channels: Critical for Homeostasis and Neuron-Glia SignalingA new perspective on the role of the CREB family of transcription factors in memory consolidation via adult hippocampal neurogenesisMECP2 disorders: from the clinic to mice and back
P2860
Q21131923-B35B4CB0-03BD-4BBA-ABA1-0C745B8BF6EDQ22337196-370A9E13-C3A0-46F6-B02E-D31A45FE6E7DQ24321278-8E0E5947-03C3-4340-91A7-1A03E4B43048Q24324098-70DA08E3-0A8A-4784-8896-C229BEC383E4Q24596970-F19BEF1D-5537-4B6C-8DC1-07C1902F9A55Q24600763-1D99BEA9-316B-4DBB-8300-F1EC9CF9E149Q24603693-DDA2D8DF-952A-43B1-B529-3093D5D2CDECQ24622025-8C05EF0E-DCA1-4525-B5D8-1A92439EE54EQ24624411-D093295F-3152-4D5C-AB85-66530D64CFCEQ24629465-B62F8024-4C8D-489F-AB91-0A93E774FC2AQ24632189-6496DF30-6285-4BE9-92C9-5A13DB51C784Q24632499-E3DBEA83-EF28-472A-AAD1-7B85A26C4C6CQ24632941-A669F833-F2ED-43E3-9342-09D424DFE4D4Q24633450-F6F16268-21F5-48F9-A2EB-9E735BDA5B15Q24633571-8ED3A8D1-A0F3-4E28-ABE1-3BB2798B641EQ24633673-F8E94BFB-137D-467D-8303-B70FF724B9CAQ24644531-DBC0DC55-CD74-4FD5-8491-2608A85166DEQ24650396-1E12D5FB-1230-43AC-A450-D88A46747654Q24651382-FBBB3613-61FE-4336-A352-F5F604229FC2Q24651541-A7E72ECF-0771-432F-B524-34F3482831E6Q24652603-3B87D8DA-9853-4CEA-A246-A9D6D18E6308Q24654169-2F3C1007-FB74-4F14-A945-64F058C63F80Q24655487-D9C8099D-2032-4B76-AD7A-E9654FA84660Q24657549-1A946509-F70E-47B5-A758-A191433F8D56Q26740071-2ECF8B0B-BDB9-4A3F-86B9-3C6FF0BCC46CQ26741427-967EAA02-41F3-4FA2-B74B-79766204222BQ26742136-3017C098-57A2-41FD-BE4B-F56560F87C1AQ26744563-B4437FD1-86BA-4750-907C-6AE0C3D60E57Q26745958-9634C01B-9100-4C67-9FC9-0D3048223648Q26747013-1515AB2F-5D17-43D0-A29B-0A6AE5B2922AQ26748761-1262562E-C3A1-4523-8F7A-FF43818AA8D3Q26765596-B1C632D3-0588-4F10-A4CF-3AF595659A1FQ26768284-9A6870BB-AE2A-4532-BE4B-D959598DC500Q26771812-4238B751-853D-4222-8958-33BC028C803DQ26772307-B1DA57AB-B47B-4FC2-8635-4762BD6F8357Q26772909-387AAC15-2529-4175-805E-DFCAC38F2117Q26782594-35E66630-09AB-4F3D-809C-76AE505555CDQ26782952-FFDE26F5-28AB-47CB-BD63-9E46011CDFA3Q26785386-14CB1F5F-A2D4-444C-BF2A-13D989F35ECEQ26799760-8FB18C1E-CFEA-4A68-B281-F775C209A84A
P2860
MeCP2, a key contributor to neurological disease, activates and represses transcription
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
MeCP2, a key contributor to neurological disease, activates and represses transcription
@ast
MeCP2, a key contributor to neurological disease, activates and represses transcription
@en
MeCP2, a key contributor to neurological disease, activates and represses transcription
@nl
type
label
MeCP2, a key contributor to neurological disease, activates and represses transcription
@ast
MeCP2, a key contributor to neurological disease, activates and represses transcription
@en
MeCP2, a key contributor to neurological disease, activates and represses transcription
@nl
prefLabel
MeCP2, a key contributor to neurological disease, activates and represses transcription
@ast
MeCP2, a key contributor to neurological disease, activates and represses transcription
@en
MeCP2, a key contributor to neurological disease, activates and represses transcription
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
MeCP2, a key contributor to neurological disease, activates and represses transcription
@en
P2093
Stephen T C Wong
Sung Yun Jung
Xiaobo Zhou
P2860
P304
P3181
P356
10.1126/SCIENCE.1153252
P407
P577
2008-05-30T00:00:00Z